Summary
The product Masteron Propionate 100 mg/ml, manufactured by PrimePharma, was tested to verify its potency and authenticity. The sample, identified by batch number PP1774, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis determined a measured concentration of 105.81 mg/ml of Drostanolone Propionate, reflecting an accuracy of 105.81%, with a 5.81% variance above the labeled claim.
The testing process commenced on 2 May 2023, with the sample received on 11 May 2023, and the analysis completed on 15 May 2023. While this result indicates accurate dosing, it is essential to evaluate reseller-submitted testing with careful scrutiny, as batch selection may influence the results. Independent third-party verification remains critical to ensuring consistent product quality across the market. This report is provided to support harm reduction and educational efforts.
Detailed Report
Product Overview
- Manufacturer: PrimePharma
- Product Name: Masteron Propionate 100 mg/ml
- Active Ingredient: Drostanolone Propionate
- Batch Number: PP1774
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #29399
- Testing Ordered: 2 May 2023
- Sample Received: 11 May 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 105.81 mg/ml
- Accuracy: 105.81% (5.81% above the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/29399_9X3B8WDMALRA
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This test report was funded and submitted by the reseller Opitropin.EU, which may reflect a more accurate representation of market-available products than manufacturer submissions. However, reseller-funded testing still requires scrutiny. Resellers might select batches known to meet specifications, which could misrepresent the consistency of products received by end consumers.
The lab, Janoshik Analytical, has a reputation for transparent and reliable analysis, adding credibility to the results. Nevertheless, further testing by independent third-party organizations is recommended to confirm the consistency of batches across the market. Transparency in testing practices ensures consumer confidence and supports harm reduction efforts.
Conclusion
The analysis confirms that Masteron Propionate 100 mg/ml by PrimePharma is slightly overdosed at 105.81% of the label claim, with a measured concentration of 105.81 mg/ml. While this result aligns with quality manufacturing practices, additional independent testing is encouraged to validate consistency across multiple batches. This report serves as an educational tool to aid informed decision-making and support harm reduction practices.
Disclaimer: This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
